Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates.

Fraser CC, Altreuter DH, Ilyinskii P, Pittet L, LaMothe RA, Keegan M, Johnston L, Kishimoto TK.

Vaccine. 2014 May 19;32(24):2896-903. doi: 10.1016/j.vaccine.2014.02.024. Epub 2014 Feb 26.

2.

Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.

Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.

J Mol Recognit. 1993 Jun;6(2):81-94.

PMID:
7508238
3.

The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity.

Laubreton D, Bay S, Sedlik C, Artaud C, Ganneau C, Dériaud E, Viel S, Puaux AL, Amigorena S, Gérard C, Lo-Man R, Leclerc C.

Cancer Immunol Immunother. 2016 Mar;65(3):315-25. doi: 10.1007/s00262-016-1802-0. Epub 2016 Feb 4.

4.

Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines.

Falugi F, Petracca R, Mariani M, Luzzi E, Mancianti S, Carinci V, Melli ML, Finco O, Wack A, Di Tommaso A, De Magistris MT, Costantino P, Del Giudice G, Abrignani S, Rappuoli R, Grandi G.

Eur J Immunol. 2001 Dec;31(12):3816-24.

6.

Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems.

Elliott SL, Pye S, Le T, Mateo L, Cox J, Macdonald L, Scalzo AA, Forbes CA, Suhrbier A.

Vaccine. 1999 Apr 9;17(15-16):2009-19.

PMID:
10217601
7.
9.

A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.

Greenstein JL, Schad VC, Goodwin WH, Brauer AB, Bollinger BK, Chin RD, Kuo MC.

J Immunol. 1992 Jun 15;148(12):3970-7.

PMID:
1376346
10.

Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.

Mortara L, Gras-Masse H, Rommens C, Venet A, Guillet JG, Bourgault-Villada I.

J Virol. 1999 May;73(5):4447-51.

11.

Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.

Zinckgraf JW, Sposato M, Zielinski V, Powell D, Treanor JJ, von Hofe E.

Vaccine. 2009 Aug 27;27(39):5393-401. doi: 10.1016/j.vaccine.2009.06.081. Epub 2009 Jul 9.

PMID:
19596415
12.

The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.

Benferhat R, Martinon F, Krust B, Le Grand R, Hovanessian AG.

Mol Immunol. 2009 Feb;46(4):705-12. doi: 10.1016/j.molimm.2008.10.001. Epub 2008 Nov 17.

PMID:
19010547
14.

Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization.

Shaw DM, Stanley CM, Partidos CD, Steward MW.

Mol Immunol. 1993 Aug;30(11):961-8.

PMID:
7688851
15.

Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.

Raju R, Diethelm-Okita B, Okita D, Conti-Fine BM.

J Autoimmun. 1996 Feb;9(1):79-88.

PMID:
8845057
16.

Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate.

Kaliyaperumal A, Chauhan VS, Talwar GP, Raghupathy R.

Eur J Immunol. 1995 Dec;25(12):3375-80.

PMID:
8566026
17.

Activation of tumor-specific CD4(+) T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy.

Dissanayake SK, Thompson JA, Bosch JJ, Clements VK, Chen PW, Ksander BR, Ostrand-Rosenberg S.

Cancer Res. 2004 Mar 1;64(5):1867-74.

18.

Bystander stimulation of activated CD4+ T cells of unrelated specificity following a booster vaccination with tetanus toxoid.

Di Genova G, Savelyeva N, Suchacki A, Thirdborough SM, Stevenson FK.

Eur J Immunol. 2010 Apr;40(4):976-85. doi: 10.1002/eji.200940017.

19.

A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responses.

Rosa DS, Ribeiro SP, Almeida RR, Mairena EC, Postól E, Kalil J, Cunha-Neto E.

PLoS One. 2011 Feb 11;6(2):e16921. doi: 10.1371/journal.pone.0016921.

20.

CD4+ T helper cell response is required for memory in CD8+ T lymphocytes induced by a poly(I:C)-adjuvanted MHC I-restricted peptide epitope.

Qiu F, Cui Z.

J Immunother. 2007 Feb-Mar;30(2):180-9. Erratum in: J Immunother (1997). 2007 Jul-Aug;30(5):576.

PMID:
17471165

Supplemental Content

Support Center